Whitehawk Therapeutics (WHWK) Change in Accured Expenses (2010 - 2026)
Whitehawk Therapeutics (WHWK) reported Change in Accured Expenses of -$3.5 million for Q1 2026, down 458.36% year-over-year from $975000.0 in Q1 2025, and down 739.93% quarter-over-quarter from $546000.0 in Q4 2025.
Whitehawk Therapeutics (WHWK) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 17 years of Change in Accured Expenses data on file, last reported at -$3.5 million in Q1 2026.
- Change in Accured Expenses for Q1 2026 came in at -$3.5 million, down 458.36% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.7 million (down 496.86% YoY), and the FY2025 annual result was -$202000.0, down 200.0% from the prior year.
- Change in Accured Expenses fell to -$3.5 million in Q1 2026 per WHWK's latest filing, from $546000.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $5.0 million in Q3 2022 and troughed at -$5.1 million in Q2 2023.
- A 5-year average of -$27066.7 and a median of $394000.0 in 2024 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2022 and 2025: Change in Accured Expenses plunged 797.47% in 2022, then jumped 384.38% in 2025.
- A 5-year view of Change in Accured Expenses shows it stood at $1.3 million in 2022, then soared by 269.53% to $4.8 million in 2023, then sank by 103.99% to -$192000.0 in 2024, then jumped by 384.38% to $546000.0 in 2025, then sank by 739.93% to -$3.5 million in 2026.
- Business Quant data shows WHWK's Change in Accured Expenses at -$3.5 million in Q1 2026, $546000.0 in Q4 2025, and -$546000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 931,000.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 70.50 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Whitehawk Therapeutics | 288.03 Mn | 164.98 Mn | - | -3.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.49 Mn |
| Mar 31, 2026 | -3.49 Mn |
| Dec 31, 2025 | 546,000.00 |
| Dec 31, 2025 | 546,000.00 |
| Sep 30, 2025 | -546,000.00 |
| Sep 30, 2025 | -546,000.00 |
| Jun 30, 2025 | -1.18 Mn |
| Jun 30, 2025 | -1.18 Mn |
| Mar 31, 2025 | 975,000.00 |
| Mar 31, 2025 | 975,000.00 |
| Dec 31, 2024 | -192,000.00 |
| Dec 31, 2024 | -192,000.00 |
| Sep 30, 2024 | 394,000.00 |
| Sep 30, 2024 | 394,000.00 |
| Dec 31, 2023 | 4.82 Mn |
| Dec 31, 2023 | 4.82 Mn |
| Sep 30, 2023 | 1.72 Mn |
| Sep 30, 2023 | 1.72 Mn |
| Jun 30, 2023 | -5.13 Mn |
| Jun 30, 2023 | -5.13 Mn |